Use of ceftriaxone in patients with severe leptospirosis

International Journal of Antimicrobial Agents

Volumn 28, Issue 3, 2006, Pages 259-261

  Raptis, Lampros ^a   Pappas, Georgios ^b   Akritidis, Nikolaos ^a  

^a G HATZIKOSTA GENERAL HOSPITAL   (Greece)

^b Institute of Continuing Medical Education of Ioannina   (Greece)

Author keywords

Ceftriaxone; Leptospirosis; Treatment

Indexed keywords

CEFTRIAXONE; PENICILLIN G;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LEPTOSPIROSIS; MALE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; FEMALE; HUMANS; LEPTOSPIROSIS; MALE; MIDDLE AGED;

EID: 33747147391     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.04.011     Document Type: Article

References (25)

1. McBride A.J., Athanazio D.A., Reis M.G., and Ko A.I. Leptospirosis. Curr Opin Infect Dis 18 (2005) 376-386
2. Bharti A.R., Nally J.E., Ricaldi J.N., et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3 (2003) 757-771
3. Jansen A., Schoneberg I., Frank C., Alpers K., Schneider T., and Stark K. Leptospirosis in Germany, 1962-2003. Emerg Infect Dis 11 (2005) 1048-1054
4. Sejvar J., Bancroft E., Winthrop K., et al. Leptospirosis in 'Eco-Challenge' athletes, Malaysian Borneo, 2000. Emerg Infect Dis 9 (2003) 702-707
5. Ko A.I., Galvao Reis M., Ribeiro Dourado C.M., Johnson Jr. W.D., and Riley L.W. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354 (1999) 820-825
6. Sarkar U., Nascimento S.F., Barbosa R., et al. Population-based case-control investigation of risk factors for leptospirosis during an urban epidemic. Am J Trop Med Hyg 66 (2002) 605-610
7. Levett P.N. Leptospirosis. Clin Microbiol Rev 14 (2001) 296-326
8. Segura E.R., Ganoza C.A., Campos K., et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 40 (2005) 343-351
9. Antoniadis A., LeDuc J.W., Acritidis N., Alexiou-Daniel S., Kyparissi A., and Saviolakis G.A. Hemorrhagic fever with renal syndrome in Greece: clinical and laboratory characteristics. Rev Infect Dis 11 Suppl. 4 (1989) S891-S896
10. Nakou K., Liamis G., Elisaf M.S., and Siamopoulos K.C. Low normal potassium levels in acute renal failure: evidence of leptospirosis. Infection 28 (2000) 196
11. Edwards C.N., and Evarard C.O. Hyperamylasemia and pancreatitis in leptospirosis. Am J Gastroenterol 86 (1991) 1665-1668
12. Sacramento E., Lopes A.A., Costa E., Passos O.L., Costa Y.A., and Matos E.D. Electrocardiographic alterations in patients hospitalized with leptospirosis in the Brazilian city of Salvador. Arq Bras Cardiol 78 (2002) 267-270
13. Edwards C.N., and Levett P.N. Prevention and treatment of leptospirosis. Expert Rev Anti Infect Ther 2 (2004) 293-298
14. Sehgal S.C., Sugunan A.P., Murhekar M.V., Sharma S., and Vijayachari P. Randomized controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 13 (2000) 249-255
15. Edwards C.N., Nicholson G.D., Hassell T.A., Everard C.O.R., and Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 39 (1988) 388-390
16. Costa E., Lopes A.A., Sacramento E., et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo 45 (2003) 141-145
17. Katz A.R., Ansdell V.E., Effler P.V., Middleton C.R., and Sasaki D.M. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 33 (2001) 1834-1841
18. Watt G., Padre L.P., Tuazon M.L., et al. Placebo-controlled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1 (1988) 433-435
19. Guidigli F, Castro AA, Atallah AN. Antibiotics for preventing leptospirosis. Cochrane Database Syst Rev 2000;4:CD001305.
20. Emmanouilides C.A., Kohn O.F., and Garibaldi R. Leptospirosis complicated by a Jarisch-Herxheimer reaction and adult respiratory distress syndrome: case report. Clin Infect Dis 18 (1994) 1004-1006
21. Friedland J.S., and Warrell D.A. The Jarisch-Herxheimer reaction in leptospirosis: possible pathogenesis and review. Rev Infect Dis 13 (1991) 207-210
22. Suputtamongkol Y., Niwattayakul K., Suttinont C., et al. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 39 (2004) 1417-1424
23. Truccolo J., Charavay F., Merien F., and Perolat P. Quantitative PCR assay to evaluate ampicillin, ofloxacin, and doxycycline for treatment of experimental leptospirosis. Antimicrob Agents Chemother 46 (2002) 848-853
24. Panaphut T., Domrongkitchaiporn S., Vibhagool A., Thinkamrop B., and Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 36 (2003) 1507-1513
25. Cachay E.R., and Vinetz J.M. A global research agenda for leptospirosis. J Postgrad Med 51 (2005) 174-178